البحث | SPARK Innovation Hub

Thomas Joeethan أضاف وظيفة جديدة أخرى
2026-06-12 11:28:34 -

WHO Antimicrobial Resistance in Nigeria Strengthening the Fight Against Drug Resistance
Antimicrobial resistance (AMR) has become one of the most serious public health challenges facing the world today. In Nigeria the growing resistance of bacteria viruses fungi and parasites to medicines threatens the effectiveness of treatments that millions of people rely on every day. As this challenge continues to grow WHO Antimicrobial Resistance in Nigeria initiatives have become a critical...

0 التعليقات 0 المشاركات 95 مشاهدة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
Mindy Hausler أضاف وظيفة جديدة أخرى
2026-06-24 09:35:08 -

Gefitinib in Clinical Oncology: Efficacy, Safety, and Emerging Research Frontiers
What Is Gefitinib? Gefitinib is a small molecule, highly selective EGFR tyrosine kinase inhibitor (EGFR-TKI). It is primarily used for the treatment of non-small cell lung cancer (NSCLC) with activating EGFR mutations. Gefitinib functions as an EGFR inhibitor by selectively binding to the ATP-binding site of the EGFR tyrosine kinase domain. This binding prevents the autophosphorylation of...

0 التعليقات 0 المشاركات 68 مشاهدة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!